Kaplan-Meier survival analyses showed that glioma patients with high expression levels of IL33 had shorter overall survival than those with low levels, the result of ST2 expression was the same (Figure 1E and 1F). The gene discussed is IL1RL1; the disease is central nervous system cancer.